FDA approves drugs for breast cancer
On July 18, the U.S. Food and Drug Administration (FDA) approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal…
Oncology
Introduction to immunotherapy: What nurses need to know about emerging therapies
Understanding these rapidly evolving treatments will help you advocate for patients and manage side effects. By Beth Boseki, MSN, RN, OCN, CCRP; Lauren FInaldi, BSN,…
FDA approves first biosimilar to Neulasta
On June 4, the U.S. Food and Drug Administration (FDA) approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of…
Breast cancer treatment game changer?
A friend of mine has a daughter who’s expecting her second child and was just diagnosed with breast cancer. She’s currently undergoing low-dose chemotherapy…
Nurse inventions that change lives
The ingenuity of nurses should never be underestimated. While doing some research for our Nurses Week for a Month celebration, I came across an…
So you’re interested in research?
Have you ever thought about going into research. Based on a recent conversation I had with a nurse researcher, it sounds like an exciting…
All-Pro Nursing Team Awards
In celebration of Nurses Week, American Nurse Today launched the All-Pro Nursing Team Awards. First Place: Quick action grants a family’s final wish Coordinators…
Caring for patients with special needs—Share your stories
This month, I’m going to be paying attention to nursing and patients with special needs, with an emphasis on developmental and intellectual disorders. I’ve…
When the heart stops: Life-giving updates on cardiac arrest
Timely intervention saves lives. Takeaways: Nurses can save lives after in-hospital cardiac arrest if skills and knowledge are up-to-date. Survival rates after cardiac arrest…
Physical wellness: A must for sustained energy
Nurses are tireless advocates when promoting physical health and well-being for our patients. Yet, in a recent study of 1,790 nurses across the United…
FDA approves new breast cancer treatment for patients with a specific genetic mutation
On Jan. 12, the U.S. Food and Drug Administration (FDA) expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients…
FDA approves drugs for breast cancer
On July 18, the U.S. Food and Drug Administration (FDA) approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment…
Introduction to immunotherapy: What nurses need to know about emerging therapies
Understanding these rapidly evolving treatments will help you advocate for patients and manage side effects. By Beth Boseki, MSN, RN, OCN, CCRP; Lauren…
FDA approves first biosimilar to Neulasta
On June 4, the U.S. Food and Drug Administration (FDA) approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the…
Breast cancer treatment game changer?
A friend of mine has a daughter who’s expecting her second child and was just diagnosed with breast cancer. She’s currently undergoing…
Nurse inventions that change lives
The ingenuity of nurses should never be underestimated. While doing some research for our Nurses Week for a Month celebration, I came…
So you’re interested in research?
Have you ever thought about going into research. Based on a recent conversation I had with a nurse researcher, it sounds like…
All-Pro Nursing Team Awards
In celebration of Nurses Week, American Nurse Today launched the All-Pro Nursing Team Awards. First Place: Quick action grants a family’s final…
Caring for patients with special needs—Share your stories
This month, I’m going to be paying attention to nursing and patients with special needs, with an emphasis on developmental and intellectual…
When the heart stops: Life-giving updates on cardiac arrest
Timely intervention saves lives. Takeaways: Nurses can save lives after in-hospital cardiac arrest if skills and knowledge are up-to-date. Survival rates after…
Physical wellness: A must for sustained energy
Nurses are tireless advocates when promoting physical health and well-being for our patients. Yet, in a recent study of 1,790 nurses across…
FDA approves new breast cancer treatment for patients with a specific genetic mutation
On Jan. 12, the U.S. Food and Drug Administration (FDA) expanded the approved use of Lynparza (olaparib tablets) to include the treatment…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.